BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zilberman-Rudenko J, Shawver LM, Wessel AW, Luo Y, Pelletier M, Tsai WL, Lee Y, Vonortas S, Cheng L, Ashwell JD, Orange JS, Siegel RM, Hanson EP. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease. Proc Natl Acad Sci U S A 2016;113:1612-7. [PMID: 26802121 DOI: 10.1073/pnas.1518163113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Yuan J, Najafov A, Py BF. Roles of Caspases in Necrotic Cell Death. Cell 2016;167:1693-704. [PMID: 27984721 DOI: 10.1016/j.cell.2016.11.047] [Cited by in Crossref: 131] [Cited by in F6Publishing: 129] [Article Influence: 26.2] [Reference Citation Analysis]
2 Xu W, Rush JS, Graham DB, Cao Z, Xavier RJ. USP15 Deubiquitinates CARD9 to Downregulate C-Type Lectin Receptor-Mediated Signaling. Immunohorizons 2020;4:670-8. [PMID: 33093067 DOI: 10.4049/immunohorizons.2000036] [Reference Citation Analysis]
3 Hedrich CM. Shaping the spectrum - From autoinflammation to autoimmunity. Clin Immunol 2016;165:21-8. [PMID: 26948930 DOI: 10.1016/j.clim.2016.03.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
4 Melin N, Sánchez-Taltavull D, Fahrner R, Keogh A, Dosch M, Büchi I, Zimmer Y, Medová M, Beldi G, Aebersold DM, Candinas D, Stroka D. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell Death Dis 2021;12:366. [PMID: 33824326 DOI: 10.1038/s41419-021-03654-3] [Reference Citation Analysis]
5 Zeng P, Ma J, Yang R, Liu YC. Immune Regulation by Ubiquitin Tagging as Checkpoint Code. Curr Top Microbiol Immunol 2017;410:215-48. [PMID: 28929193 DOI: 10.1007/82_2017_64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Osório J. A20–NEMO interaction prevents autoinflammation. Nat Rev Rheumatol 2016;12:134-134. [DOI: 10.1038/nrrheum.2016.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol 2017;18:832-42. [DOI: 10.1038/ni.3777] [Cited by in Crossref: 192] [Cited by in F6Publishing: 152] [Article Influence: 38.4] [Reference Citation Analysis]
8 Yan M, Li D, Aknai S, Zhu H, Abudureyim M. Mutation analysis of the TNFAIP3 in A20 haploinsufficiency: A case report. Medicine (Baltimore) 2021;100:e25954. [PMID: 34011076 DOI: 10.1097/MD.0000000000025954] [Reference Citation Analysis]
9 Shan B, Pan H, Najafov A, Yuan J. Necroptosis in development and diseases. Genes Dev. 2018;32:327-340. [PMID: 29593066 DOI: 10.1101/gad.312561.118] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 28.8] [Reference Citation Analysis]
10 Lu Y, Qi Y, Li L, Yan Y, Wei J, Yao D, Wu J, Deng H, Deng J, Ye S, Chen H, Chen Q, Gao H, Han L, Lu C. The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes. Front Pharmacol 2022;12:759741. [DOI: 10.3389/fphar.2021.759741] [Reference Citation Analysis]
11 Hong J, Wang Y, Hu BC, Xu L, Liu JQ, Chen MH, Wang JZ, Han F, Zheng Y, Chen X, Li Q, Yang XH, Sun RH, Mo SJ. Transcriptional downregulation of microRNA-19a by ROS production and NF-κB deactivation governs resistance to oxidative stress-initiated apoptosis. Oncotarget 2017;8:70967-81. [PMID: 29050336 DOI: 10.18632/oncotarget.20235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
12 Sharma R, George A, Nimmagadda M, Ortolan D, Karla BS, Qureshy Z, Bose D, Dejene R, Liang G, Wan Q, Chang J, Jha BS, Memon O, Miyagishima KJ, Rising A, Lal M, Hanson E, King R, Campos MM, Ferrer M, Amaral J, McGaughey D, Bharti K. Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nat Commun 2021;12:7293. [PMID: 34911940 DOI: 10.1038/s41467-021-27488-x] [Reference Citation Analysis]
13 Ma J, Wang H, Guo S, Yi X, Zhao T, Liu Y, Shi Q, Gao T, Li C, Guo W. A20 promotes melanoma progression via the activation of Akt pathway. Cell Death Dis 2020;11:794. [PMID: 32968045 DOI: 10.1038/s41419-020-03001-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xiong H, Luo M, Ju Y, Zhao Z, Zhang M, Xu R, Ren Y, Yang G, Mei Z. Triterpene saponins from Guo-gang-long attenuate collagen-induced arthritis via regulating A20 and inhibiting MAPK pathway. J Ethnopharmacol 2021;269:113707. [PMID: 33358855 DOI: 10.1016/j.jep.2020.113707] [Reference Citation Analysis]
15 Wu Y, He X, Huang N, Yu J, Shao B. A20: a master regulator of arthritis. Arthritis Res Ther 2020;22:220. [PMID: 32958016 DOI: 10.1186/s13075-020-02281-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Qin M, Luo Y, Lu S, Sun J, Yang K, Sun G, Sun X. Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling. Front Pharmacol 2017;8:953. [PMID: 29311947 DOI: 10.3389/fphar.2017.00953] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
17 Lee Y, Wessel AW, Xu J, Reinke JG, Lee E, Kim SM, Hsu AP, Zilberman-Rudenko J, Cao S, Enos C, Brooks SR, Deng Z, Lin B, de Jesus AA, Hupalo DN, Piotto DG, Terreri MT, Dimitriades VR, Dalgard CL, Holland SM, Goldbach-Mansky R, Siegel RM, Hanson EP. Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype. J Clin Invest 2022;132:e128808. [PMID: 35289316 DOI: 10.1172/JCI128808] [Reference Citation Analysis]
18 Zhu B, Zhu L, Xia L, Xiong Y, Yin Q, Rui K. Roles of Ubiquitination and Deubiquitination in Regulating Dendritic Cell Maturation and Function. Front Immunol 2020;11:586613. [PMID: 33329564 DOI: 10.3389/fimmu.2020.586613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R. NF-κB: At the Borders of Autoimmunity and Inflammation. Front Immunol 2021;12:716469. [PMID: 34434197 DOI: 10.3389/fimmu.2021.716469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li N, Shi Y, Zhang P, Sang J, Li F, Deng H, Lv Y, Han Q, Liu Z. Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population. Virol J 2017;14:148. [PMID: 28784141 DOI: 10.1186/s12985-017-0814-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 Björk A, Thorlacius GE, Mofors J, Richardsdotter Andersson E, Ivanchenko M, Tingström J, James T, Brokstad KA, Cox RJ, Jonsson R, Kvarnström M, Wahren-Herlenius M. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome. Rheumatology (Oxford) 2020;59:1651-61. [PMID: 31665501 DOI: 10.1093/rheumatology/kez509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kohn LL, Braun M, Cordoro KM, McCalmont TH, Shah SD, Frieden IJ, Mathur AN. Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review. Pediatr Dermatol 2022. [PMID: 34989033 DOI: 10.1111/pde.14905] [Reference Citation Analysis]
23 Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, Seppänen MRJ. Behçet disease (BD) and BD-like clinical phenotypes: NF-κB pathway in mucosal ulcerating diseases. Scand J Immunol 2020;92:e12973. [PMID: 32889730 DOI: 10.1111/sji.12973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhao H, Xia Y, Gan H. Calcitriol Ameliorates AngiotensinII-Induced Renal Injury Partly via Upregulating A20. Inflammation 2017;40:1884-93. [PMID: 28744711 DOI: 10.1007/s10753-017-0629-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Kul Cinar O, Romano M, Guzel F, Brogan PA, Demirkaya E. Paediatric Behçet’s Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics. JCM 2022;11:1278. [DOI: 10.3390/jcm11051278] [Reference Citation Analysis]
26 Zhang R, Xu L, Zhang D, Hu B, Luo Q, Han D, Li J, Shen C. Cardioprotection of Ginkgolide B on Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Regulation of A20-NF-κB Pathway. Front Immunol 2018;9:2844. [PMID: 30619251 DOI: 10.3389/fimmu.2018.02844] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
27 Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome. Nat Immunol 2017;18:861-9. [PMID: 28722711 DOI: 10.1038/ni.3772] [Cited by in Crossref: 254] [Cited by in F6Publishing: 255] [Article Influence: 50.8] [Reference Citation Analysis]
28 Bikker R, Christmann M, Preuß K, Welz B, Friesenhagen J, Dittrich-breiholz O, Huber R, Brand K. TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD. Cellular Signalling 2017;37:123-35. [DOI: 10.1016/j.cellsig.2017.06.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
29 Zhang Y, Guo X, Yan W, Chen Y, Ke M, Cheng C, Zhu X, Xue W, Zhou Q, Zheng L, Wang S, Wu B, Liu X, Ma L, Huang L, Huang K. ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ. Nat Commun 2017;8:2164. [PMID: 29255244 DOI: 10.1038/s41467-017-02355-w] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 10.6] [Reference Citation Analysis]
30 Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, Einarsdottir E, Sahu B, Kilpinen S, Rounioja S, Fogarty CL, Glumoff V, Kulmala P, Katayama S, Tamene F, Trotta L, Morgunova E, Krjutškov K, Nurmi K, Eklund K, Lagerstedt A, Helminen M, Martelius T, Mustjoki S, Taipale J, Saarela J, Kere J, Varjosalo M, Seppänen M. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol 2017;140:782-96. [PMID: 28115215 DOI: 10.1016/j.jaci.2016.10.054] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
31 Razani B, Whang MI, Kim FS, Nakamura MC, Sun X, Advincula R, Turnbaugh JA, Pendse M, Tanbun P, Achacoso P, Turnbaugh PJ, Malynn BA, Ma A. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. Nat Immunol 2020;21:422-33. [PMID: 32205880 DOI: 10.1038/s41590-020-0634-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
32 Song Y, Hu B, Xu L, Liu J, Chen X, Zheng Y, Chen M, Wang J, Sun R, Mo S. Productive transcription of miR-124-3p by RelA and RNA polymerase II directs RIP1 ubiquitination-dependent apoptosis resistance during hypoxia. Experimental Cell Research 2019;378:21-31. [DOI: 10.1016/j.yexcr.2019.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Hawiger J, Zienkiewicz J. Decoding inflammation, its causes, genomic responses, and emerging countermeasures. Scand J Immunol 2019;90:e12812. [PMID: 31378956 DOI: 10.1111/sji.12812] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
34 Sanders OD, Rajagopal L, Rajagopal JA. Does oxidatively damaged DNA drive amyloid-β generation in Alzheimer's disease? A hypothesis. J Neurogenet 2021;:1-7. [PMID: 34282704 DOI: 10.1080/01677063.2021.1954641] [Reference Citation Analysis]
35 Ko MS, Biswas T, Mulero MC, Bobkov AA, Ghosh G, Huxford T. Structurally plastic NEMO and oligomerization prone IKK2 subunits define the behavior of human IKK2:NEMO complexes in solution. Biochim Biophys Acta Proteins Proteom 2020;1868:140526. [PMID: 32853772 DOI: 10.1016/j.bbapap.2020.140526] [Reference Citation Analysis]
36 Maubach G, Schmädicke AC, Naumann M. NEMO Links Nuclear Factor-κB to Human Diseases. Trends Mol Med 2017;23:1138-55. [PMID: 29128367 DOI: 10.1016/j.molmed.2017.10.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
37 Reid S, Scholey JW. Recent Approaches to Targeting Canonical NFκB Signaling in the Early Inflammatory Response to Renal IRI. J Am Soc Nephrol 2021;32:2117-24. [PMID: 34108233 DOI: 10.1681/ASN.2021010069] [Reference Citation Analysis]
38 Gao S, Wu J, Liang L, Xu R. RNF8 negatively regulates NF-kappaB signaling by targeting IkappaB kinase: implications for the regulation of inflammation signaling. Biochem Biophys Res Commun 2017;488:189-95. [PMID: 28499869 DOI: 10.1016/j.bbrc.2017.05.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]